Abstract
Adiponectin receptor 1 (ADIPOR1) is a lipid and glucose metabolism regulator that possesses intrinsic ceramidase activity. Mutations of the ADIPOR1 gene have been associated with nonsyndromic and syndromic retinitis pigmentosa. Here, we show that the absence of AdipoR1 in mice leads to progressive photoreceptor degeneration, significant reduction of electroretinogram amplitudes, decreased retinoid content in the retina, and reduced cone opsin expression. Single-cell RNA-Seq results indicate that ADIPOR1 encoded the most abundantly expressed ceramidase in mice and one of the 2 most highly expressed ceramidases in the human retina, next to acid ceramidase ASAH1. We discovered an accumulation of ceramides in the AdipoR1–/– retina, likely due to insufficient ceramidase activity for healthy retina function, resulting in photoreceptor death. Combined treatment with desipramine/L-cycloserine (DC) lowered ceramide levels and exerted a protective effect on photoreceptors in AdipoR1–/– mice. Moreover, we observed improvement in cone-mediated retinal function in the DC-treated animals. Lastly, we found that prolonged DC treatment corrected the electrical responses of the primary visual cortex to visual stimuli, approaching near-normal levels for some parameters. These results highlight the importance of ADIPOR1 ceramidase in the retina and show that pharmacological inhibition of ceramide generation can provide a therapeutic strategy for ADIPOR1-related retinopathy.
Original language | English |
---|---|
Article number | A25 |
Journal | JCI insight |
Volume | 7 |
Issue number | 4 |
DOIs | |
State | Published - Feb 22 2022 |
Bibliographical note
Publisher Copyright:© 2022, Lewandowski et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Funding
This research was supported in part by grants from NIH to KP (grant R24EY027283); and NEI grants for J. Luu (F30 EY031566 and T32GM007250). Ceramide analysis by AFMP was supported by the Mass Spectrometry Core of the Salk Institute with funding from NIH-NCI CCSG (P30 014195, NIH 1S10OD021815-01) and the Helmsley Center for Genomic Medicine.
Funders | Funder number |
---|---|
Helmsley Center for Genomic Medicine | |
Mass Spectrometry Core of the Salk Institute | 1S10OD021815-01, P30 014195 |
National Institutes of Health (NIH) | |
National Eye Institute (NEI) | F30 EY031566, T32GM007250, R24EY027283 |
National Eye Institute (NEI) |
ASJC Scopus subject areas
- General Medicine